{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:39:59Z","timestamp":1785465599519,"version":"3.56.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>HELLP syndrome remains a leading cause of maternal and neonatal mortality and morbidity worldwide, which symptoms include hemolysis, elevated liver enzymes and low platelet count. The objective of this study was to determine whether HELLP is associated with AT1-AA. The positive rate and titer of AT1-AA in plasma from pregnant women were determined, and the correlation of AT1-AA titer with the grade of HELLP was analyzed. A HELLP rat model established by intravenous injection of AT1-AA. Our experimental results show the AT1-AA titer and positive rate were significantly higher in HELLP group, and AT1-AA titer were positively correlated with the level of TNF-\u03b1 and ET-1 in plasma and the grade of HELLP syndrome. The results of animal experiments showed that the typical features of HELLP in the pregnant rats after AT1-AA injection. The levels of TNF-\u03b1 and ET-1 in plasma and liver tissue were significantly increased in AT1-AA-treated rats compared with control rats. The HELLP syndrome induced by AT1-AA was attenuated markedly after administration of losartan. These data support the hypothesis that one the potential pathway that AT1-AA induce damage to capillary endothelial cells and liver during pregnancy is through activation of TNF-\u03b1 and ET-1.<\/jats:p>","DOI":"10.1038\/s41598-017-18553-x","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T11:20:48Z","timestamp":1515064848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Role and mechanism of AT1-AA in the pathogenesis of HELLP syndrome"],"prefix":"10.1038","volume":"8","author":[{"given":"Shurui","family":"Bu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"key":"18553_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2393-9-8","volume":"9","author":"K Haram","year":"2009","unstructured":"Haram, K., Svendsen, E. & Abildgaard, U. The HELLP syndrome: Clinical issues and management. MC Pregnancy Childbirth. 9, 8 (2009).","journal-title":"MC Pregnancy Childbirth."},{"key":"18553_CR2","first-page":"16","volume":"94","author":"D Murray","year":"2001","unstructured":"Murray, D. et al. The HELLP syndrome: maternal and perinatal outcome. Ir Med J. 94, 16\u201318 (2001).","journal-title":"Ir Med J."},{"key":"18553_CR3","first-page":"661","volume":"52","author":"FN Cho","year":"2007","unstructured":"Cho, F. N. et al. Successful management of a pregnant woman with HELLP syndrome, pulmonary edema, postpartum hemorrhage and acute renal failure, using early hemodialysis, intravenous immunoglobulin and noninvasive monitoring: a case report. J Reprod Med. 52, 661\u2013663 (2007).","journal-title":"J Reprod Med."},{"key":"18553_CR4","doi-asserted-by":"publisher","first-page":"910751","DOI":"10.1155\/2014\/910751","volume":"2014","author":"K Haram","year":"2014","unstructured":"Haram, K., Mortensen, J. H. & Nagy, B. Genetic aspects of preeclampsia and the HELLP syndrome. J Pregnancy. 2014, 910751 (2014).","journal-title":"J Pregnancy."},{"key":"18553_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.molimm.2015.02.030","volume":"67","author":"F Jean","year":"2015","unstructured":"Jean, F. et al. The Complement system and adverse pregnancy outcomes. Mol Immunol. 67, 56\u201370 (2015).","journal-title":"Mol Immunol."},{"key":"18553_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s12072-016-9705-x","volume":"10","author":"G Kim","year":"2016","unstructured":"Kim, G. et al. Renin-angiotensin system inhibitors and fibrosis in chronic liver disease: a systematic review. Hepatol Int. 10, 819\u2013828 (2016).","journal-title":"Hepatol Int."},{"key":"18553_CR7","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1471-0528.2008.01702.x","volume":"115","author":"JM Schutte","year":"2008","unstructured":"Schutte, J. M., Schuitemaker, N. W., van Roosmalen, J. & Steegers, E. A. Substandard care in maternal mortality due to hypertensive disease in pregnancy in the Netherlands. BJOG. 115, 732\u2013736 (2008).","journal-title":"BJOG."},{"key":"18553_CR8","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nm.1856","volume":"14","author":"CC Zhou","year":"2008","unstructured":"Zhou, C. C. et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med. 14, 855\u2013862 (2008).","journal-title":"Nat Med."},{"key":"18553_CR9","doi-asserted-by":"publisher","first-page":"11495","DOI":"10.3390\/ijms150711495","volume":"15","author":"HP Wang","year":"2014","unstructured":"Wang, H. P. et al. Exposure to AT1 receptor autoantibodies during pregnancy increases susceptibility of the maternal heart to postpartum ischemia-reperfusion injury in rats. Int J Mol Sci. 15, 11495\u201311509 (2014).","journal-title":"Int J Mol Sci."},{"key":"18553_CR10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/01.AOG.0000268512.26170.ad","volume":"110","author":"E Bornstein","year":"2007","unstructured":"Bornstein, E., Barnhard, Y., Atkin, R. & Divon, M. Y. HELLP syndrome: a rare, early presentation at 17 weeks of gestation. Obstet Gynecol. 110, 525\u2013527 (2007).","journal-title":"Obstet Gynecol."},{"key":"18553_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0301-2115(00)00534-0","volume":"97","author":"T Fischer","year":"2001","unstructured":"Fischer, T. et al. HELLP syndrome in the 18th week of gestation in association with elevated angiotensin AT(1)-receptor autoantibodies. Eur J Obstet Gynecol Reprod Biol. 97, 255\u2013257 (2001).","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"18553_CR12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3109\/14767058.2013.773308","volume":"26","author":"JN Martin Jr","year":"2013","unstructured":"Martin, J. N. Jr et al. Hellp syndrome and composite major maternal morbidity: importance of Mississippi classification system. J Matern Fetal Neonatal Med. 26, 1201\u20131206 (2013).","journal-title":"J Matern Fetal Neonatal Med."},{"key":"18553_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jss.2004.07.020","volume":"123","author":"CR Newton","year":"2005","unstructured":"Newton, C. R., Curran, B. & Victorino, G. P. Angiotensin II type 1 receptor activation increases microvascular permeability via a calcium dependent process. J Surg Res. 123, 33\u201339 (2005).","journal-title":"J Surg Res."},{"key":"18553_CR14","doi-asserted-by":"publisher","first-page":"e67020","DOI":"10.1371\/journal.pone.0067020","volume":"8","author":"Z Jin","year":"2013","unstructured":"Jin, Z. et al. Antibodies against AT1 receptors are associated with vascular endothelial and smooth muscle function impairment: protective effects of hydroxysafflor yellow A. PLOS ONE. 8, e67020, https:\/\/doi.org\/10.1371\/journal.pone.0067020 (2013).","journal-title":"PLOS ONE."},{"key":"18553_CR15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/abbs\/gmv088","volume":"47","author":"WH Zhang","year":"2015","unstructured":"Zhang, W. H. et al. Study of Mechanism of agonistic angiotensin II type-1 receptor autoantibody amplified contractile response to Ang II. Acta Biochim Biophys Sin. 47, 851\u2013856 (2015).","journal-title":"Acta Biochim Biophys Sin."},{"key":"18553_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00404-015-3803-1","volume":"293","author":"S Karakus","year":"2016","unstructured":"Karakus, S., Akkar, O. B. & Yildiz, C. Serum levels of ET-1, M30, and angiopoietins-1 and \u22122 in HELLP syndrome and preeclampsia compared to controls. Arch Gynecol Obatet. 293, 351\u2013359 (2016).","journal-title":"Arch Gynecol Obatet."},{"key":"18553_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s004040050238","volume":"262","author":"S Bussen","year":"1999","unstructured":"Bussen, S., S\u00fctterlin, M. & Steck, T. Plasma endothelin and big endothelin levels in women with severe preeclampsia or HELLPsyndrome. Arch Gynecol Obstet. 262, 113\u2013119 (1999).","journal-title":"Arch Gynecol Obstet."},{"key":"18553_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000292699","volume":"35","author":"A Halim","year":"1993","unstructured":"Halim, A. et al. HELLP syndrome-like biochemical parameters obtained with endothelin-1 injections in rabbits. Gynecol Obstet Invest. 35, 193\u2013198 (1993).","journal-title":"Gynecol Obstet Invest."},{"key":"18553_CR19","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/HYPERTENSIONAHA.109.137935","volume":"54","author":"B LaMarca","year":"2009","unstructured":"LaMarca, B. et al. Hypertension in response to autoantibodies to the angiotensin II type Ireceptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension. 54, 905\u2013909 (2009).","journal-title":"Hypertension."},{"issue":"S1","key":"18553_CR20","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1096\/fasebj.30.1_supplement.1212.4","volume":"30","author":"J Faulkner","year":"2016","unstructured":"Faulkner, J. et al. Vitamin D lowers blood pressure, ET-1 and sFlt-1 in AT1 autoantibody induced hypertension during pregnancy. FASEB J. 30(S1), 1212\u20131214 (2016).","journal-title":"FASEB J."},{"key":"18553_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3109\/10641955.2013.835820","volume":"33","author":"K Wallace","year":"2014","unstructured":"Wallace, K. et al. Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndrome. Hypertens Pregnancy. 33, 41\u201354 (2014).","journal-title":"Hypertens Pregnancy."},{"key":"18553_CR22","first-page":"1707","volume":"16","author":"A Ozler","year":"2012","unstructured":"Ozler, A. et al. Serum levels of neopterin, tumor necrosis factor-alpha and Interleukin-6 in preeclampsia: relationship with disease severity. Eur Rev Med Pharmacol Sci. 16, 1707\u20131712 (2012).","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"18553_CR23","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1161\/HYPERTENSIONAHA.110.150540","volume":"55","author":"RA Irani","year":"2010","unstructured":"Irani, R. A. et al. Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling. Hypertension. 55, 1246\u20131253 (2010).","journal-title":"Hypertension."},{"key":"18553_CR24","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/abbs\/gms087","volume":"44","author":"WR Chai","year":"2012","unstructured":"Chai, W. R. et al. Angiotensin II type I receptor agonistic autoantibody-induced apoptosis in neonatal rat cardiomyocytes is dependent on the generation of tumor necrosis factor-a. Acta Biochim Biophys Sin. 44, 984\u2013990 (2012).","journal-title":"Acta Biochim Biophys Sin."},{"key":"18553_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0002-9378(90)90376-I","volume":"162","author":"BM Sibai","year":"1990","unstructured":"Sibai, B. M. The HELLP syndrome (hemolysis,elevated liver enzymes,and low platelets): much a do about nothing? Am J Obstet Gynecoi. 162, 311\u2013316 (1990).","journal-title":"Am J Obstet Gynecoi."},{"key":"18553_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep29036","volume":"6","author":"F Liu","year":"2016","unstructured":"Liu, F. et al. Role of agonistic autoantibodies against type-1 angiotensin II receptor in the pathogenesis of retinopathy in preeclampsia. Sci Rep. 6, 29036, https:\/\/doi.org\/10.1038\/ srep29036 (2016).","journal-title":"Sci Rep."},{"key":"18553_CR27","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1093\/abbs\/gmr096","volume":"43","author":"Z Jin","year":"2011","unstructured":"Jin, Z. et al. Changes in cardiac structure and function in rats immunized by angiotensin type 1 receptor peptides. Acta Biochim Biophys Sin. 43, 970\u2013976 (2011).","journal-title":"Acta Biochim Biophys Sin."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18553-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18553-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18553-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T08:14:36Z","timestamp":1719735276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18553-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["18553"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-18553-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,10]]},"assertion":[{"value":"30 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"279"}}